Original Research | ||||||||||||
Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru.
|
This Article Cited By the following articles
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response Front. Immunol. 2020; 11(): . | 1 |
Yoga-based Lifestyle Intervention for Prevention and Management of Type 2 Diabetes Mellitus and Associated Complications: A Clinical Research Review 2020; 24(3): 125. | 2 |
Internet-Based Sources of Health Information: A Systematic Literature Review (Preprint) 2019; (): . | 3 |
Adverse Effects of eHealth Applications Replacing or Complementing Healthcare Contacts: A Scoping Review (Preprint) 2018; (): . | 4 |
Using Passive Smartphone Sensing for Improved Risk Stratification of Patients with Depression and Diabetes: A Cross-Sectional Observational Study (Preprint) 2018; (): . | 5 |
How to Cite this Article |
Pubmed Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. Natl J Physiol Pharm Pharmacol. 2017; 7(3): 232-235. doi:10.5455/njppp.2017.7.0825508092016 Web Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. https://www.njppp.com/?mno=240752 [Access: January 02, 2023]. doi:10.5455/njppp.2017.7.0825508092016 AMA (American Medical Association) Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. Natl J Physiol Pharm Pharmacol. 2017; 7(3): 232-235. doi:10.5455/njppp.2017.7.0825508092016 Vancouver/ICMJE Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. Natl J Physiol Pharm Pharmacol. (2017), [cited January 02, 2023]; 7(3): 232-235. doi:10.5455/njppp.2017.7.0825508092016 Harvard Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru (2017) Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. Natl J Physiol Pharm Pharmacol, 7 (3), 232-235. doi:10.5455/njppp.2017.7.0825508092016 Turabian Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. 2017. Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. National Journal of Physiology, Pharmacy and Pharmacology, 7 (3), 232-235. doi:10.5455/njppp.2017.7.0825508092016 Chicago Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. "Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 232-235. doi:10.5455/njppp.2017.7.0825508092016 MLA (The Modern Language Association) Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru. "Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes." National Journal of Physiology, Pharmacy and Pharmacology 7.3 (2017), 232-235. Print. doi:10.5455/njppp.2017.7.0825508092016 APA (American Psychological Association) Style Rajani Santhakumari Nagothu, Archana Rajagopalan, Yogananda Reddy Indla, Rajesh Paluru (2017) Beneficial effects of yogasanas and pranayama in limiting the cognitive decline in Type 2 diabetes. National Journal of Physiology, Pharmacy and Pharmacology, 7 (3), 232-235. doi:10.5455/njppp.2017.7.0825508092016 |